[Retracted] MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS

Authors

Institutions

Publication Details

Journal
Oncology Letters
Published
2026-02-09
DOI
https://doi.org/10.3892/ol.2026.15482
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[Retracted] MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS

Shang Zhen, Yi Xiao, Taoran Deng, Changliang Su
Oncology Letters
MicroRNA in disease regulation
article

[Retracted] MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS

Shang Zhen, Yi Xiao, Taoran Deng, Changliang Su
article en

Abstract

No abstract available for this paper.
Oncology LettersVol. 31(4)
Tongji Hospital (CN), Huazhong University of Science and Technology (CN)
Zero hunger
Openalex Percentile: Top 63%
MicroRNA in disease regulation
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

[Retracted] MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS — Shang Zhen, Yi Xiao, et al. · Oncology Letters (2026) | TGRS Research Map | TGRS